eBook: Development of Next-Generation Antibodies for Therapeutics
Antibody-based therapeutics represent an important advancement in the progress of infectious disease therapy and cancer treatment options. The discovery and development of monoclonal antibodies (mAbs) has led to an improved understanding of their therapeutic potential against emerging infectious diseases including COVID-19 and offers one of the most successful therapeutic strategies for both hematologic cancers and solid tumors in recent years.
In this third edition eBook, we look at some of the successful discovery and development methods for next-generation monoclonal antibody-based therapeutics and vaccines. These methods take advantage of innovative, high-throughput, and automated solutions, such as the iQue®, Incucyte®, and Octet® advanced cell and protein analysis platforms from Sartorius, which are designed to enable rapid identification and characterization of candidate molecules with superior target reactivity and optimized functionality.
Learn more about Sartorius solutions for mAb Discovery & Development at www.sartorius.com/mAb-development.